Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-070159

Options or other derivatives

  • Director acquired 31,344 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FORBES CHRISTOPHER · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-18 Grant or award : show line 1 in the form Common Stock Option (right to buy) +27,882 64,107 D
2014-11-18 Grant or award : show line 2 in the form Common Stock Option (right to buy) +3,462 $0.42 $1,454 67,569 D
Loading xslF345X03/form471647_20141120050204-.xml…